特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962720

動物用医薬品の世界市場予測:2019-2028年

Global Veterinary Medicines Market Forecast 2019-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 219 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
動物用医薬品の世界市場予測:2019-2028年
出版日: 2020年10月02日
発行: Inkwood Research
ページ情報: 英文 219 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における動物用医薬品の市場規模は、2019年から2028年の予測期間中に、4.53%のCAGRが見込まれています。家畜数の増加、医療費の上昇、ペット所有の拡大、および病気の有病率の増加は、市場の成長に影響を与えると予測されています。

動物は、即時の治療と注意を必要とするさまざまな病状を経験します。このような治療に使用されるワクチン、薬用飼料添加物、および薬物は、動物用医薬品と呼ばれます。これらは、真菌やバクテリアの成長を防止または遅らせます。動物との交流は生活の質を高めることで知られており、人間の健康にプラスの影響を与えます。世界中でペットの所有が大幅に増加しています。また、ワクチン接種や病気のタイムリーな診断に関する動物の健康に対する意識の高まりは、世界における動物用医薬品の需要の急増に貢献しています。同時に、動物と人間の健康に対する獣医用ワクチンの副作用、基本的なインフラストラクチャの欠如、費用のかかる予防接種、および厳格な規制が、市場の成長を妨げています。

当レポートでは、動物用医薬品の世界市場について調査し、市場の概要、市場に影響を及ぼす要因の分析、各セグメント・サブセグメント・地域における市場予測、および主要企業のプロファイルなどを提供しています。

目次

第1章 調査範囲・調査手法

  • 調査目的
  • 調査範囲
  • 調査手法
  • 前提条件・制限事項

第2章 エグゼクティブサマリー

  • 市場規模・推計
  • 市場概要

第3章 市場力学

  • 市場定義
  • 主な促進要因
    • 家畜の数の急増
    • 動物医療費の上昇
    • ペットの所有の増加
    • 動物におけるいくつかの病気の有病率の上昇
  • 主な抑制要因
    • 動物用医薬品に関する厳格な規制
    • 動物用ワクチンに関連するヒトおよび動物の健康への副作用
    • 新興経済諸国における畜産のための基本的なインフラ施設の欠如
    • 予防接種の高コスト
    • 北米における菜食主義とヴィーガニズムの人気の高まり

第4章 主な分析

  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 規制の枠組み
  • COVID-19が動物用医薬品市場に与える影響
  • 機会マトリックス
  • ベンダー情勢
  • 主な投資の考察

第5章 市場:動物種類別

  • コンパニオンアニマル
  • 家畜動物

第6章 市場:流通チャネル別

  • 小売り獣医薬局
  • 獣医病院の薬局

第7章 市場:投与経路別

  • 非経口経路
  • 経口経路
  • 局所経路

第8章 市場:製品別

  • 薬物
    • 抗感染症
    • 抗炎症薬
    • 寄生虫駆除剤
  • ワクチン
    • 不活化ワクチン
    • 弱毒化ワクチン
    • 組換えワクチン
  • 薬用飼料添加物
    • 抗生物質
    • アミノ酸

第9章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • ポーランド
    • ベルギー
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • オーストラリア・ニュージーランド
    • インド
    • 韓国
    • タイ
    • インドネシア
    • ベトナム
    • その他アジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第10章 企業プロファイル

  • ARCHER DANIELS MIDLAND
  • BIOGENESIS BAGO SA
  • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • CEVA SANTE ANIMALE
  • DECHRA PHARMACEUTICALS PLC
  • ELANCO
  • EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • HESTER BIOSCIENCES LIMITED
  • INDIAN IMMUNOLOGICALS LIMITED
  • KINDRED BIOSCIENCES
  • MERCK & CO
  • NEOGEN CORPORATION
  • VETOQUINOL (SOPARFIN SCA)
  • VIRBAC SA
  • ZOETIS
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - VETERINARY MEDICINES
  • TABLE 2: NUMBER OF HOUSEHOLDS IN THE UNITED STATES OWNING A PET (MILLION)
  • TABLE 3: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL COMPANION ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL COMPANION ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL ORAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL ORAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL TOPICAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL TOPICAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 26: GLOBAL DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 28: GLOBAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL VACCINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL VACCINES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL VACCINES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 41: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 43: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 44: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 45: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 46: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIVESTOCK SPECIES POPULATION IN INDIA, 2019, (MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019
  • FIGURE 7: GLOBAL VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 10: GLOBAL VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 13: GLOBAL VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019
  • FIGURE 17: GLOBAL VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 29: THE UNITED STATES VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: CANADA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 32: GERMANY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: FRANCE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: THE UNITED KINGDOM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: ITALY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: RUSSIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: POLAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: BELGIUM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: ASIA PACIFIC VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: CHINA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: JAPAN VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: INDIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: SOUTH KOREA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: THAILAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: INDONESIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: VIETNAM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA PACIFIC VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD VETERINARY MEDICINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: LATIN AMERICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
目次
Product Code: 34133

KEY FINDINGS

The global veterinary medicines market is estimated to grow with a CAGR of 4.53% during the forecast period, 2019-2028. The increasing livestock population, rising healthcare expenditure, growing pet ownership, and rising prevalence of diseases, are projected to influence the growth of the market.

MARKET INSIGHTS

Animals undergo different medical conditions that require immediate treatment and attention. Vaccines, medicated feed additives, and drugs, used for such treatment are called veterinary medicines. These prevent or slow the growth of the fungi and bacteria. The company of animals is known to enhance the quality of life, and has a positive impact on human health. There has been a considerable rise in pet ownership across the globe. In 2018 alone, 1 in 80 million households owned a pet in Europe. Thus, such a huge population is fueling the demand for veterinary medicines. Also, the rising awareness of animal health with regard to vaccine regimes and timely diagnosis of diseases are contributing to the surge in demand for veterinary medicines across the world. At the same time, the side effects of veterinary vaccines on animal & human health, lack of basic infrastructure, costly vaccinations, and strict regulations, are set to hamper the market growth.

REGIONAL INSIGHTS

The geographical analysis of the global veterinary medicines market includes the evaluation of Asia Pacific, Europe, North America, and the rest of the world. North America is set to dominate the global market throughout the forecast period. The increasing number of pet owners is one of the dominant factors contributing to the growth of the region.

COMPETITIVE INSIGHTS

The global veterinary medicines market is evaluated to be highly competitive over the forecast period. Some of the major players in the market include, Archer Daniels Midland, Biogenesis Bago SA, Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. SURGING LIVESTOCK POPULATION
    • 3.2.2. INCREASING ANIMAL HEALTHCARE EXPENDITURE
    • 3.2.3. GROWING PET OWNERSHIP
    • 3.2.4. RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
    • 3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
    • 3.3.3. LACK OF BASIC INFRASTRUCTURE FACILITIES FOR THE VETERINARY ANIMALS IN THE UNDERDEVELOPED ECONOMIES
    • 3.3.4. HIGH COST OF VACCINATIONS
    • 3.3.5. RISING POPULARITY OF VEGETARIANISM AND VEGANISM IN NORTH AMERICA

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. VALUE CHAIN ANALYSIS
  • 4.3. REGULATORY FRAMEWORK
  • 4.4. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE
  • 4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY ANIMAL TYPE

  • 5.1. COMPANION ANIMALS
  • 5.2. LIVESTOCK ANIMALS

6. MARKET BY DISTRIBUTION CHANNEL

  • 6.1. RETAIL VETERINARY PHARMACIES
  • 6.2. VETERINARY HOSPITAL PHARMACIES

7. MARKET BY ROUTE OF ADMINISTRATION

  • 7.1. PARENTERAL ROUTE
  • 7.2. ORAL ROUTE
  • 7.3. TOPICAL ROUTE

8. MARKET BY PRODUCT

  • 8.1. DRUGS
    • 8.1.1. ANTI-INFECTIVE
    • 8.1.2. ANTI-INFLAMMATORY
    • 8.1.3. PARASITICIDE
  • 8.2. VACCINES
    • 8.2.1. INACTIVATED VACCINES
    • 8.2.2. ATTENUATED VACCINES
    • 8.2.3. RECOMBINANT VACCINES
  • 8.3. MEDICATED FEED ADDITIVES
    • 8.3.1. ANTIBIOTICS
    • 8.3.2. AMINO ACIDS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. RUSSIA
    • 9.2.6. POLAND
    • 9.2.7. BELGIUM
    • 9.2.8. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. AUSTRALIA & NEW ZEALAND
    • 9.3.4. INDIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. THAILAND
    • 9.3.7. INDONESIA
    • 9.3.8. VIETNAM
    • 9.3.9. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES

  • 10.1. ARCHER DANIELS MIDLAND
  • 10.2. BIOGENESIS BAGO SA
  • 10.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • 10.4. CEVA SANTE ANIMALE
  • 10.5. DECHRA PHARMACEUTICALS PLC
  • 10.6. ELANCO
  • 10.7. EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • 10.8. HESTER BIOSCIENCES LIMITED
  • 10.9. INDIAN IMMUNOLOGICALS LIMITED
  • 10.10. KINDRED BIOSCIENCES
  • 10.11. MERCK & CO
  • 10.12. NEOGEN CORPORATION
  • 10.13. VETOQUINOL (SOPARFIN SCA)
  • 10.14. VIRBAC SA
  • 10.15. ZOETIS
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.